The Publication Plan remembers Professor Doug Altman, founder of the EQUATOR network, who passed away last month.
CBI’s Publication Planning Meeting is back by popular demand with new dates and an exciting new programme.
In a recent MAP newsletter, ISMPP share an update from ASCO on their new open access option for industry-funded research.
Mary Yianni, Publisher at Taylor and Francis, reviews the different models of peer review and the emerging role of preprints.
Don’t forget! From 1 July 2018, ICMJE requires all reports of clinical trial data to include a data sharing statement.
How can journals, institutions, funders and societies improve and standardise the current authorship system?
Missed the 14th Annual Meeting of ISMPP? Read the second part of our meeting report to get up to speed!
Missed the 14th Annual Meeting of ISMPP? Read our meeting report to get up to speed!
A new study from the AllTrials team sheds light on clinical trial reporting rates by non-industry sponsors.
A new, regular series in The BMJ will highlight a different unreported clinical trial every week, with the intention of improving reporting rates.
Dr Richard Smith reviews the potential pitfalls of textbooks in a recent opinion piece for The BMJ.
Can preprints be cited in the same way as papers published in a peer reviewed journal, or do we need to define new standards?
The CONSORT extension for reporting non-pharmacological interventions was introduced in 2008. A recent study looks at the impact of this guidance on reporting standards.
Are we too willing to accept big data as fact? Find out how scientific publishing can learn from common mistakes arising from bad data practice.
As PubMed Commons closes due to lack of use, what does this tell us about engagement with medical publications and post-publication peer review?
The FDAAA 2007 requires clinical trials to make results publicly available 12 months after study completion. A new tool from TrialsTracker provides a live online report on compliance.